Possible explanations for the discrepancies in defining IDH mutations prognostic role between available studies could in part rely on the rarity of the disease (small sample size), heterogeneity of included population (patients with different chondrosarcoma subtypes and different grade), the employment of different sequencing tools. This evidence concerns the gene IDH2 and chondrosarcoma.